{"id":49788,"date":"2025-12-02T22:27:19","date_gmt":"2025-12-02T14:27:19","guid":{"rendered":"https:\/\/flcube.com\/?p=49788"},"modified":"2025-12-02T22:27:20","modified_gmt":"2025-12-02T14:27:20","slug":"shanghai-bao-pharma-ipo-hkex-raises-hk1-billion-for-biotech-pipeline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=49788","title":{"rendered":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline"},"content":{"rendered":"\n<p><strong>Shanghai Bao Pharmaceuticals Co., Ltd.<\/strong> (HKG: 2659) successfully listed on the <strong>Hong Kong Stock Exchange<\/strong> today, raising over <strong>HK$1 billion<\/strong> through a global offering of <strong>37,911,700 shares<\/strong> at <strong>HK$26.38 per share<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-offering-summary-amp-company-profile\">Offering Summary &amp; Company Profile<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Attribute<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Shanghai Bao Pharmaceuticals Co., Ltd. (2659.HK)<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>02\u202fDec\u202f2025<\/td><\/tr><tr><td><strong>Shares Offered<\/strong><\/td><td>37,911,700 shares<\/td><\/tr><tr><td><strong>Offer Price<\/strong><\/td><td>HK$26.38 per share<\/td><\/tr><tr><td><strong>Total Proceeds<\/strong><\/td><td>Over HK$1 billion<\/td><\/tr><tr><td><strong>Founded<\/strong><\/td><td>2019<\/td><\/tr><tr><td><strong>Sector<\/strong><\/td><td>Biotechnology<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-focus-areas\">Strategic Focus Areas<\/h2>\n\n\n\n<p>Bao-Pharma concentrates on four therapeutic and technology domains:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>High-volume subcutaneous injection<\/strong> drug delivery<\/li>\n\n\n\n<li><strong>Antibody-mediated autoimmune diseases<\/strong><\/li>\n\n\n\n<li><strong>Assisted reproduction<\/strong> therapeutics<\/li>\n\n\n\n<li><strong>Recombinant biopharmaceuticals<\/strong> development<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-pipeline-breakdown\">Product Pipeline Breakdown<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Development Stage<\/th><th>Count<\/th><th>Key Assets<\/th><\/tr><\/thead><tbody><tr><td><strong>Core Products<\/strong><\/td><td>3<\/td><td>KJ017, KJ103, SJ02<\/td><\/tr><tr><td><strong>Clinical Stage<\/strong><\/td><td>4<\/td><td>BJ007, KJ015, SJ04, KJ101<\/td><\/tr><tr><td><strong>Preclinical<\/strong><\/td><td>5<\/td><td>BJ008, BJ009, BJ045, BJ047, BJ044<\/td><\/tr><tr><td><strong>Total Pipeline<\/strong><\/td><td><strong>12<\/strong><\/td><td>All self-developed investigational products<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-opportunity-amp-strategic-outlook\">Market Opportunity &amp; Strategic Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China Biotech IPO Market<\/strong>: 2025 has seen robust investor appetite for pre-revenue biotech listings, with average oversubscription rates exceeding 8x<\/li>\n\n\n\n<li><strong>Therapeutic Focus<\/strong>: Subcutaneous injection platform addresses growing demand for patient-friendly dosing in chronic diseases<\/li>\n\n\n\n<li><strong>Revenue Timeline<\/strong>: Core products KJ017 and KJ103 expected to enter pivotal trials in 2026, with potential 2028 commercialization<\/li>\n\n\n\n<li><strong>R&amp;D Investment<\/strong>: HK$1 billion proceeds will fund clinical development through Phase 3, expand manufacturing capacity, and advance preclinical assets<\/li>\n\n\n\n<li><strong>Valuation Metrics<\/strong>: At HK$26.38, Bao-Pharma debuts with a market capitalization of approximately HK$4.5 billion<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding Bao-Pharma&#8217;s development timelines, product commercialization, and market prospects. Actual results may differ due to clinical, regulatory, and competitive uncertainties.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025120200035_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2025120200035_c.\"><\/object><a id=\"wp-block-file--media-d31b97bf-e79c-4bfb-9837-0d8e247e4d48\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025120200035_c.pdf\">2025120200035_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/2025120200035_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-d31b97bf-e79c-4bfb-9837-0d8e247e4d48\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange&#8230;<\/p>\n","protected":false},"author":1,"featured_media":49789,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[3258,4484,72],"class_list":["post-49788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-bao-pharmaceuticals","tag-hkg-2659","tag-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=49788\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline\" \/>\n<meta property=\"og:description\" content=\"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=49788\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-02T14:27:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T14:27:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline\",\"datePublished\":\"2025-12-02T14:27:19+00:00\",\"dateModified\":\"2025-12-02T14:27:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788\"},\"wordCount\":253,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0208.webp\",\"keywords\":[\"Bao Pharmaceuticals\",\"HKG: 2659\",\"IPO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49788#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=49788\",\"name\":\"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0208.webp\",\"datePublished\":\"2025-12-02T14:27:19+00:00\",\"dateModified\":\"2025-12-02T14:27:20+00:00\",\"description\":\"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49788\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0208.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0208.webp\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49788#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=49788","og_locale":"en_US","og_type":"article","og_title":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline","og_description":"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.","og_url":"https:\/\/flcube.com\/?p=49788","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-02T14:27:19+00:00","article_modified_time":"2025-12-02T14:27:20+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=49788#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=49788"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline","datePublished":"2025-12-02T14:27:19+00:00","dateModified":"2025-12-02T14:27:20+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=49788"},"wordCount":253,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=49788#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","keywords":["Bao Pharmaceuticals","HKG: 2659","IPO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=49788#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=49788","url":"https:\/\/flcube.com\/?p=49788","name":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=49788#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=49788#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","datePublished":"2025-12-02T14:27:19+00:00","dateModified":"2025-12-02T14:27:20+00:00","description":"Shanghai Bao Pharmaceuticals Co., Ltd. (HKG: 2659) successfully listed on the Hong Kong Stock Exchange today, raising over HK$1 billion through a global offering of 37,911,700 shares at HK$26.38 per share.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=49788#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=49788"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=49788#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","width":1080,"height":608,"caption":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=49788#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai Bao Pharma IPO HKEX Raises HK$1 Billion for Biotech Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0208.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49788"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49788\/revisions"}],"predecessor-version":[{"id":49791,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49788\/revisions\/49791"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/49789"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}